Emerging novel roles of neuropeptide Y in the retina: From neuromodulation to neuroprotection

Progress in Neurobiology

Volumn 112, Issue , 2014, Pages 70-79

  Santos Carvalho, Ana ^a,b   Álvaro, Ana Rita ^a,c   Martins, João ^a,d   Ambrósio, António Francisco ^a,d,e   Cavadas, Cláudia ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

Neuromodulation; Neuropeptide Y; Neuroprotection; NPY receptors; Retina; Retinal neural cells

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROTRANSMITTER;

CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETIC RETINOPATHY; GLAUCOMA; HUMAN; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA; RETINA CELL; RETINA DEVELOPMENT; REVIEW; VISUAL SYSTEM;

3,4-METHYLENEDIOXYMETHAMPHETAMINE; 5-BROMO-2′-DEOXYURIDINE; BRDU; CENTRAL NERVOUS SYSTEM; CNS; DIPEPTIDYL PEPTIDASE IV; DPP-IV; E18; EMBRIONIC DAY 18; ERK; EXTRACELLULAR SIGNAL-REGULATED KINASES; GABA; GABA TRANSPORTER 1; GAD 65; GANGLION CELL LAYER; GAT-1; GCL; GLUTAMIC ACID DECARBOXYLASE 65; HESC; HUMAN EMBRYONIC STEM CELLS; IGLURS; INL; INNER NUCLEAR LAYER; INNER PLEXIFORM LAYER; INTRACELLULAR CALCIUM; IONOTROPIC GLUTAMATE RECEPTORS; IPL; LEU; LEUCINE; MAPK; MDMA; MESSENGER RIBONUCLEIC ACID; METABOTROPIC GLUTAMATE RECEPTORS; MGLURS; MITOGEN ACTIVATED PROTEIN KINASE; MRNA; NEUROMODULATION; NEUROPEPTIDE Y; NEUROPEPTIDE Y IMMUNOREACTIVITY; NEUROPROTECTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE - SOLUBLE GUANYLYL CYCLASE; NO; NOS-SGC; NPY; NPY RECEPTOR TYPE 1; NPY RECEPTORS; NPY Y(1); NPY-IR; ONL; OPL; OUTER NUCLEAR LAYER; OUTER PLEXIFORM LAYER; P7; PHOTORECEPTOR OUTER SEGMENT; PKA; POS; POSTNATAL DAY 7; PRO; PROLINE; PROTEIN KINASE A; RETINA; RETINAL NEURAL CELLS; RETINAL PIGMENTED EPITHELIUM; RPE; [CA(2+)](I); Γ-AMINOBUTYRIC ACID;

ANIMALS; HUMANS; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROPEPTIDE Y; RETINAL NEURONS; SYNAPTIC TRANSMISSION;

EID: 84890802011     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.10.002     Document Type: Review

References (149)

1. Agasse F., Bernardino L., Kristiansen H., Christiansen S.H., Ferreira R., Silva B., Grade S., Woldbye D.P., Malva J.O. Neuropeptide Y promotes neurogenesis in murine subventricular zone. Stem Cells (Dayton, Ohio) 2008, 26:1636-1645.
2. Ahmad I. Stem cells: new opportunities to treat eye diseases. Invest. Ophthalmol. Vis. Sci. 2001, 42:2743-2748.
3. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science 1983, 221:877-879.
4. Alvaro A.R., Martins J., Araujo I.M., Rosmaninho-Salgado J., Ambrosio A.F., Cavadas C. Neuropeptide Y stimulates retinal neural cell proliferation involvement of nitric oxide. J. Neurochem. 2008, 105:2501-2510.
5. Alvaro A.R., Martins J., Costa A.C., Fernandes E., Carvalho F., Ambrosio A.F., Cavadas C. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy. Neuroscience 2008, 152:97-105.
6. i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors. J. Neurochem. 2009, 109:1508-1515.
7. Alvaro A.R., Rosmaninho-Salgado J., Santiago A.R., Martins J., Aveleira C., Santos P.F., Pereira T., Gouveia D., Carvalho A.L., Grouzmann E., Ambrosio A.F., Cavadas C. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells. Neurochem. Int. 2007, 50:757-763.
8. Ammar D.A., Hughes B.A., Thompson D.A. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses. Invest. Ophthalmol. Vis. Sci. 1998, 39:1870-1878.
9. Ault D.T., Werling L.L. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors. Eur. J. Pharmacol. 1999, 386:145-153.
10. Bagnoli P., Dal Monte M., Casini G. Expression of neuropeptides and their receptors in the developing retina of mammals. Histol. Histopathol. 2003, 18:1219-1242.
11. Baptista S., Bento A.R., Goncalves J., Bernardino L., Summavielle T., Lobo A., Fontes-Ribeiro C., Malva J.O., Agasse F., Silva A.P. Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures. Neuropharmacology 2012, 62:2413-2423.
12. Bernardos R.L., Barthel L.K., Meyers J.R., Raymond P.A. Late-stage neuronal progenitors in the retina are radial Muller glia that function as retinal stem cells. J. Neurosci. 2007, 27:7028-7040.
13. Bitran M., Tapia W., Eugenin E., Orio P., Boric M.P. Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide. Brain Res. 1999, 851:87-93.
14. Bleakman D., Harrison N.L., Colmers W.F., Miller R.J. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 1992, 107:334-340.
15. Bruun A., Ehinger B. NPY-induced neurotransmitter release from the rabbit and chicken retina. Acta Ophthalmol. (Copenh.) 1993, 71:590-596.
16. Bruun A., Ehinger B., Ekman R. Characterization of neuropeptide Y-like immunoreactivity in vertebrate retina. Exp. Eye Res. 1991, 53:539-543.
17. Bruun A., Ehinger B., Sundler F., Tornqvist K., Uddman R. Neuropeptide Y immunoreactive neurons in the guinea-pig uvea and retina. Invest. Ophthalmol. Vis. Sci. 1984, 25:1113-1123.
18. Bruun A., Ehinger B., Sytsma V., Tornqvist K. Retinal neuropeptides in the skates, Raja clavata, R. radiata, R. oscellata (Elasmobranchii). Cell Tissue Res. 1985, 241:17-24.
19. Bruun A., Tornqvist K., Ehinger B. Neuropeptide Y (NPY) immunoreactive neurons in the retina of different species. Histochemistry 1986, 86:135-140.
20. Canto Soler M.V., Gallo J.E., Dodds R.A., Hokfelt T., Villar M.J., Suburo A.M. Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina. Glia 2002, 39:320-324.
21. Cepko C.L., Austin C.P., Yang X., Alexiades M., Ezzeddine D. Cell fate determination in the vertebrate retina. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:589-595.
22. Cerda-Reverter J.M., Larhammar D. Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution. Biochem. Cell Biol. 2000, 78:371-392.
23. Chen S.-T., Shen C.-L., Wang J.-P., Chou L.-S. A comparative study of neuropeptide Y-immunoreactivity in the retina of dolphin and several other mammalian species. Zool. Stud. 1999, 38:416-422.
24. Chen J., Zhang Y., Shen P. A protein kinase C activity localized to neuropeptide Y-like neurons mediates ethanol intoxication in Drosophila melanogaster. Neuroscience 2008, 156:42-47.
25. Coles B.L., Angenieux B., Inoue T., Del Rio-Tsonis K., Spence J.R., McInnes R.R., Arsenijevic Y., van der Kooy D. Facile isolation and the characterization of human retinal stem cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15772-15777.
26. 2+ influx into rod bipolar cell terminals. Neuroscience 2004, 125:1039-1049.
27. D'Angelo I., Oh S.J., Chun M.H., Brecha N.C. Localization of neuropeptide Y1 receptor immunoreactivity in the rat retina and the synaptic connectivity of Y1 immunoreactive cells. J. Comp. Neurol. 2002, 454:373-382.
28. De Berardinis E., Auricchio G. Hydrolysis of adenosinetriphosphoric acid (ATP) in the retina and its biological significance. Ann. Ottalmol. Clin. Ocul. 1951, 77:430-453.
29. Decressac M., Prestoz L., Veran J., Cantereau A., Jaber M., Gaillard A. Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice. Neurobiol. Dis. 2009, 34:441-449.
30. Decressac M., Wright B., David B., Tyers P., Jaber M., Barker R.A., Gaillard A. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 2011, 21:233-238.
31. Doyle K.L., Hort Y.J., Herzog H., Shine J. Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis. J. Neurosci. Res. 2012, 90:1126-1135.
32. Duner H., Von Euler U.S., Pernow B. Catechol amines and substance P in the mammalian eye. Acta Physiol. Scand. 1954, 31:113-114.
33. Emsley J.G., Hagg T. Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice. Exp. Neurol. 2003, 183:298-310.
34. Ferreira R., Xapelli S., Santos T., Silva A.P., Cristovao A., Cortes L., Malva J.O. Neuropeptide Y modulation of interleukin-1 beta (IL-1{beta})-induced nitric oxide production in microglia. J. Biol. Chem. 2010, 285:41921-41934.
35. Ferriero D.M., Sagar S.M. Development of neuropeptide Y-immunoreactive neurons in the rat retina. Brain Res. Dev. Brain Res. 1989, 48:19-26.
36. Gammon C.M., Lyons S.A., Morell P. Modulation by neuropeptides of bradykinin-stimulated second messenger release in dorsal root ganglion neurons. Brain Res. 1990, 518:159-165.
37. Grandt D., Schimiczek M., Rascher W., Feth F., Shively J., Lee T.D., Davis M.T., Reeve J.R., Michel M.C. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul. Pept. 1996, 67:33-37.
38. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 1994, 113:737-740.
39. Gu J., Polak J.M., Adrian T.E., Allen J.M., Tatemoto K., Bloom S.R. Neuropeptide tyrosine (NPY) - a major cardiac neuropeptide. Lancet 1983, 1:1008-1010.
40. Haeggendal J., Malmfors T. Evidence of dopamine-containing neurons in the retina of rabbits. Acta Physiol. Scand. 1963, 59:295-296.
41. Hansel D.E., Eipper B.A., Ronnett G.V. Neuropeptide Y functions as a neuroproliferative factor. Nature 2001, 410:940-944.
42. Hansel D.E., Eipper B.A., Ronnett G.V. Regulation of olfactory neurogenesis by amidated neuropeptides. J. Neurosci. Res. 2001, 66:1-7.
43. Hastings J.A., Morris M.J., Lambert G., Lambert E., Esler M. NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro. Regul. Pept. 2004, 120:107-112.
44. Hendry S.H., Jones E.G., DeFelipe J., Schmechel D., Brandon C., Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:6526-6530.
45. Hiscock J., Straznicky C. Neuropeptide Y-like immunoreactive amacrine cells in the retina of Bufo marinus. Brain Res. 1989, 494:55-64.
46. Hiscock J., Straznicky C. Neuropeptide Y- and substance P-like immunoreactive amacrine cells in the retina of the developing Xenopus laevis. Brain Res. Dev. Brain Res. 1990, 54:105-113.
47. Hodges G.J., Jackson D.N., Mattar L., Johnson J.M., Shoemaker J.K. Neuropeptide Y and neurovascular control in skeletal muscle and skin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R546-R555.
48. Hokfelt T., Aman K., Arvidsson U., Bedecs K., Ceccatelli S., Hulting A.L., Langel U., Meister B., Pieribone V., Bartfai T. Galanin message-associated peptide (GMAP)- and galanin-like immunoreactivities: overlapping and differential distributions in the rat. Neurosci. Lett. 1992, 142:139-142.
49. Howell O.W., Doyle K., Goodman J.H., Scharfman H.E., Herzog H., Pringle A., Beck-Sickinger A.G., Gray W.P. Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J. Neurochem. 2005, 93:560-570.
50. Howell O.W., Scharfman H.E., Herzog H., Sundstrom L.E., Beck-Sickinger A., Gray W.P. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 2003, 86:646-659.
51. Howell O.W., Silva S., Scharfman H.E., Sosunov A.A., Zaben M., Shatya A., McKhann G., Herzog H., Laskowski A., Gray W.P. Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol. Dis. 2007, 26:174-188.
52. Hutsler J.J., Chalupa L.M. Neuropeptide Y immunoreactivity identifies a regularly arrayed group of amacrine cells within the cat retina. J. Comp. Neurol. 1994, 346:481-489.
53. Hutsler J.J., Chalupa L.M. Development of neuropeptide Y immunoreactive amacrine and ganglion cells in the pre- and postnatal cat retina. J. Comp. Neurol. 1995, 361:152-164.
54. Isayama T., Eldred W.D. Neuropeptide Y-immunoreactive amacrine cells in the retina of the turtle Pseudemys scripta elegans. J. Comp. Neurol. 1988, 271:56-66.
55. Isayama T., Polak J., Eldred W.D. Synaptic analysis of amacrine cells with neuropeptide Y-like immunoreactivity in turtle retina. J. Comp. Neurol. 1988, 275:452-459.
56. Jaakkola U., Pesonen U., Vainio-Jylha E., Koulu M., Pollonen M., Kallio J. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy. Exp. Clin. Endocrinol. Diabetes 2006, 114:147-152.
57. Jen P.Y., Li W.W., Yew D.T. Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience 1994, 60:727-735.
58. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11946-11950.
59. Johns P.R. Growth of the adult goldfish eye. III. Source of the new retinal cells. J. Comp. Neurol. 1977, 176:343-357.
60. Jotwani G., Itoh K., Wadhwa S. Immunohistochemical localization of tyrosine hydroxylase, substance P, neuropeptide-Y and leucine-enkephalin in developing human retinal amacrine cells. Brain Res. Dev. Brain Res. 1994, 77:285-289.
61. Kaarniranta K., Holopainen J.M., Karvonen M.K., Koulu M., Kallio J., Pesonen U., Terasvirta M., Uusitalo H., Immonen I. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration. Acta Ophthalmol. Scand. 2007, 85:188-191.
62. Kang W.S., Lim M.Y., Lee E.J., Kim I.B., Oh S.J., Brecha N.C., Park C.B., Chun M.H. Light- and electron-microscopic analysis of neuropeptide Y-immunoreactive amacrine cells in the guinea pig retina. Cell Tissue Res. 2001, 306:363-371.
63. Keffel S., Schmidt M., Bischoff A., Michel M.C. Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells. J. Pharmacol. Exp. Ther. 1999, 291:1172-1178.
64. Kiyama H., Katayama Y., Hillyard C.J., Girgis S., MacIntyre I., Emson P.C., Tohyama M. Occurrence of calcitonin gene-related peptide in the chicken amacrine cells. Brain Res. 1985, 327:367-369.
65. Kiyama H., Shiosaka S., Kuwayama Y., Shibasaki T., Ling N., Tohyama M. Corticotropin-releasing factor in the amacrine cells of the chicken retina. Brain Res. 1984, 298:197-200.
66. Kojima K., Iida M., Majima Y., Okada S., Yoshida N., Kiribuchi K. Histochemical studies on monoamine oxydase (serotonin) in the retina. Nihon Ganka Kiyo 1961, 12:861-866.
67. Koulu M., Movafagh S., Tuohimaa J., Jaakkola U., Kallio J., Pesonen U., Geng Y., Karvonen M.K., Vainio-Jylha E., Pollonen M., Kaipio-Salmi K., Seppala H., Lee E.W., Higgins R.D., Zukowska Z. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann. Med. 2004, 36:232-240.
68. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 1992, 267:10935-10938.
69. Lindeman V.F. The cholinesterase and acetylcholine content of the chick retina, with especial reference to functional activity as indicated by the pupillary constrictor reflex. Am. J. Physiol. 1947, 148:40-44.
70. Linnertz R., Wurm A., Pannicke T., Krugel K., Hollborn M., Hartig W., Iandiev I., Wiedemann P., Reichenbach A., Bringmann A. Activation of voltage-gated Na(+) and Ca(2)(+) channels is required for glutamate release from retinal glial cells implicated in cell volume regulation. Neuroscience 2011, 188:23-34.
71. Loren I., Tornqvist K., Alumets J. VIP (vasoactive intestinal polypeptide)-immunoreactive neurons in the retina of the rat. Cell Tissue Res. 1980, 210:167-170.
72. Magni P. Hormonal control of the neuropeptide Y system. Curr. Protein Pept. Sci. 2003, 4:45-57.
73. Martin S.E., Patterson R.E. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers. Am. J. Physiol. 1989, 257:H927-H934.
74. Martinez-Navarrete G.C., Angulo A., Martin-Nieto J., Cuenca N. Gradual morphogenesis of retinal neurons in the peripheral retinal margin of adult monkeys and humans. J. Comp. Neurol. 2008, 511:557-580.
75. 3H]noradrenaline release from rat hypothalamic synaptosomes via different mechanisms. Neurosci. Lett. 1995, 188:9-12.
76. Mathieu M., Tagliafierro G., Bruzzone F., Vallarino M. Neuropeptide tyrosine-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development. Brain Res. Dev. Brain Res. 2002, 139:255-265.
77. Mazzocchi G., Malendowicz L.K., Macchi C., Gottardo G., Nussdorfer G.G. Further investigations on the effects of neuropeptide Y on the secretion and growth of rat adrenal zona glomerulosa. Neuropeptides 1996, 30:19-27.
78. McDonald A.J. Localization of AMPA glutamate receptor subunits in subpopulations of non-pyramidal neurons in the rat basolateral amygdala. Neurosci. Lett. 1996, 208:175-178.
79. Medeiros M.D., Turner A.J. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 1994, 134:2088-2094.
80. Medeiros M.D., Turner A.J. Metabolism and functions of neuropeptide Y. Neurochem. Res. 1996, 21:1125-1132.
81. Michel M.C. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 1991, 12:389-394.
82. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50:143-150.
83. Michel M.C., Rascher W. Neuropeptide Y: a possible role in hypertension?. J. Hypertens. 1995, 13:385-395.
84. Milenkovic I., Weick M., Wiedemann P., Reichenbach A., Bringmann A. Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242:944-950.
85. Millar B.C., Weis T., Piper H.M., Weber M., Borchard U., McDermott B.J., Balasubramaniam A. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am. J. Physiol. 1991, 261:H1727-H1733.
86. Muske L.E., Dockray G.J., Chohan K.S., Stell W.K. Segregation of FMRF amide-immunoreactive efferent fibers from NPY-immunoreactive amacrine cells in goldfish retina. Cell Tissue Res. 1987, 247:299-307.
87. Negishi K., Kiyama H., Kato S., Teranishi T., Hatakenaka S., Katayama Y., Miki N., Tohyama M. An immunohistochemical study on the river lamprey retina. Brain Res. 1986, 362:389-393.
88. Negishi K., Wagner H.J. Differentiation of photoreceptors, glia, and neurons in the retina of the cichlid fish Aequidens pulcher; an immunocytochemical study. Brain Res. Dev. Brain Res. 1995, 89:87-102.
89. Niskanen L., Voutilainen-Kaunisto R., Terasvirta M., Karvonen M.K., Valve R., Pesonen U., Laakso M., Uusitupa M.I., Koulu M. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with retinopathy in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2000, 108:235-236.
90. Oh S.J., D'Angelo I., Lee E.J., Chun M.H., Brecha N.C. Distribution and synaptic connectivity of neuropeptide Y-immunoreactive amacrine cells in the rat retina. J. Comp. Neurol. 2002, 446:219-234.
91. Ohta K., Ito A., Tanaka H. Neuronal stem/progenitor cells in the vertebrate eye. Dev. Growth Differ. 2008, 50:253-259.
92. Olasmaa M., Terenius L. Neuropeptide Y receptor interaction with beta-adrenoceptor coupling to adenylate cyclase. Prog. Brain Res. 1986, 68:337-341.
93. Onali P., Olianas M.C. PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species. Brain Res. 1994, 641:132-134.
94. Ooto S., Akagi T., Kageyama R., Akita J., Mandai M., Honda Y., Takahashi M. Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13654-13659.
95. Osborne N.N., Beaton D.W., Boyd P.J., Walker R.J. Substance P-like immunoreactivity in the retina and optic lobe of the squid. Neurosci. Lett. 1986, 70:65-68.
96. Osborne N.N., Patel S., Terenghi G., Allen J.M., Polak J.M., Bloom S.R. Neuropeptide Y (NPY)-like immunoreactive amacrine cells in retinas of frog and goldfish. Cell Tissue Res. 1985, 241:651-656.
97. Overdick B., Kirchmair R., Marksteiner J., Fischer-Colbrie R., Troger J., Winkler H., Saria A. Presence and distribution of a new neuropeptide, secretoneurin, in human retina. Peptides 1996, 17:1-4.
98. Pirone A., Lenzi C., Marroni P., Betti L., Mascia G., Giannaccini G., Lucacchini A., Fabiani O. Neuropeptide Y in the brain and retina of the adult teleost gilthead seabream (Sparus aurata L.). Anat. Histol. Embryol. 2008, 37:231-240.
99. Pons J., Kitlinska J., Jacques D., Perreault C., Nader M., Everhart L., Zhang Y., Zukowska Z. Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth. Can. J. Physiol. Pharmacol. 2008, 86:438-448.
100. Potter E. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 1987, 83:101-106.
101. Prada Oliveira J.A., Verastegui Escolano C., Gomez Luy C., Collantes Ruiz J. Ontogenic attendance of neuropeptides in the embryo chicken retina. Histol. Histopathol. 2003, 18:1013-1026.
102. Prod'homme T., Weber M.S., Steinman L., Zamvil S.S. A neuropeptide in immune-mediated inflammation, Y?. Trends Immunol. 2006, 27:164-167.
103. Pruitt K.D., Tatusova T., Brown G.R., Maglott D.R. NCBI reference sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 2012, 40:D130-D135.
104. Rawitch A.B., Pollock H.G., Brodin L. A neuropeptide Y (NPY)-related peptide is present in the river lamprey CNS. Neurosci. Lett. 1992, 140:165-168.
105. Reh T.A., Fischer A.J. Stem cells in the vertebrate retina. Brain Behav. Evol. 2001, 58:296-305.
106. Rettori V., Milenkovic L., Aguila M.C., McCann S.M. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 1990, 126:2296-2301.
107. Rettori V., Milenkovic L., Riedel M., McCann S.M. Physiological role of neuropeptide Y (NPY) in control of anterior pituitary hormone release in the rat. Endocrinol. Exp. 1990, 24:37-45.
108. 3H]D-aspartate outflow in the kindling model of epilepsy. Synapse 2003, 49:116-124.
109. Rodrigo C., Zaben M., Lawrence T., Laskowski A., Howell O.W., Gray W.P. NPY augments the proliferative effect of FGF2 and increases the expression of FGFR1 on nestin positive postnatal hippocampal precursor cells, via the Y1 receptor. J. Neurochem. 2010, 113:615-627.
110. Rorstad O.P., Brownstein M.J., Martin J.B. Immunoreactive and biologically active somatostatin-like material in rat retina. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:3019-3023.
111. Rosmaninho-Salgado J., Alvaro A.R., Grouzmann E., Duarte E.P., Cavadas C. Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells. Peptides 2007, 28:310-314.
112. Rosmaninho-Salgado J., Araujo I.M., Alvaro A.R., Mendes A.F., Ferreira L., Grouzmann E., Mota A., Duarte E.P., Cavadas C. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide. J. Neurochem. 2009, 109:911-922.
113. Santos-Carvalho A., Aveleira C.A., Elvas F., Ambrosio A.F., Cavadas C. Neuropeptide Y receptors Y1 and Y2 are present in neurons and glial cells in rat retinal cells in culture. Invest. Ophthalmol. Vis. Sci. 2013, 54:429-443.
114. Santos-Carvalho A., Elvas F., Alvaro A.R., Ambrosio A.F., Cavadas C. Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate. Cell Death Dis. 2013, 4:e636.
115. Schmid E., Leierer J., Kieselbach G., Teuchner B., Kralinger M., Fischer-Colbrie R., Krause J.E., Nguyen Q.A., Haas G., Stemberger K., Troger J. Neurokinin A and neurokinin B in the human retina. Peptides 2006, 27:3370-3376.
116. Schmid E., Nogalo M., Bechrakis N.E., Fischer-Colbrie R., Tasan R., Sperk G., Theurl M., Beer A.G., Kirchmair R., Herzog H., Troger J. Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice. Peptides 2012, 37:252-257.
117. Schwertfeger E., Klein T., Vonend O., Oberhauser V., Stegbauer J., Rump L.C. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 2004, 369:455-461.
118. Senanayake P., Drazba J., Shadrach K., Milsted A., Rungger-Brandle E., Nishiyama K., Miura S., Karnik S., Sears J.E., Hollyfield J.G. Angiotensin II and its receptor subtypes in the human retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:3301-3311.
119. Silva A.P., Carvalho A.P., Carvalho C.M., Malva J.O. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 2001, 79:286-296.
120. Silva A.P., Pinheiro P.S., Carvalho A.P., Carvalho C.M., Jakobsen B., Zimmer J., Malva J.O. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 2003, 17:1118-1120.
121. Silva A.P., Xapelli S., Grouzmann E., Cavadas C. The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:331-347.
122. Sinclair J.R., Jacobs A.L., Nirenberg S. Selective ablation of a class of amacrine cells alters spatial processing in the retina. J. Neurosci. 2004, 24:1459-1467.
123. Sinclair J.R., Nirenberg S. Characterization of neuropeptide Y-expressing cells in the mouse retina using immunohistochemical and transgenic techniques. J. Comp. Neurol. 2001, 432:296-306.
124. Smialowska M., Domin H., Zieba B., Kozniewska E., Michalik R., Piotrowski P., Kajta M. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo. Neuropeptides 2009, 43:235-249.
125. Son M.Y., Kim M.J., Yu K., Koo D.B., Cho Y.S. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells. J. Cell. Mol. Med. 2011, 15:152-165.
126. Stanic D., Paratcha G., Ledda F., Herzog H., Kopin A.S., Hokfelt T. Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3610-3615.
127. Stone R.A., Kuwayama Y., Laties A.M. Regulatory peptides in the eye. Experientia 1987, 43:791-800.
128. Straznicky C., Hiscock J. Neuropeptide Y-like immunoreactivity in neurons of the human retina. Vis. Res. 1989, 29:1041-1048.
129. Straznicky C., Hiscock J. Neuropeptide Y-immunoreactive neurons in the retina of two Australian lizards. Arch. Histol. Cytol. 1994, 57:151-160.
130. Straznicky K., Gaze R.M. The growth of the retina in Xenopus laevis: an autoradiographic study. J. Embryol. Exp. Morphol. 1971, 26:67-79.
131. Subhedar N., Cerda J., Wallace R.A. Neuropeptide Y in the forebrain and retina of the killifish, Fundulus heteroclitus. Cell Tissue Res. 1996, 283:313-323.
132. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296:659-660.
133. Thiriet N., Agasse F., Nicoleau C., Guegan C., Vallette F., Cadet J.L., Jaber M., Malva J.O., Coronas V. NPY promotes chemokinesis and neurogenesis in the rat subventricular zone. J. Neurochem. 2011, 116:1018-1027.
134. Tropepe V., Coles B.L., Chiasson B.J., Horsford D.J., Elia A.J., McInnes R.R., van der Kooy D. Retinal stem cells in the adult mammalian eye. Science 2000, 287:2032-2036.
135. Tsuda K., Tsuda S., Goldstein M., Masuyama Y. Sodium ions attenuate the inhibitory effects of neuropeptide Y on norepinephrine release in rat hypothalamus. Am. J. Hypertens. 1995, 8:1135-1140.
136. Uckermann O., Wolf A., Kutzera F., Kalisch F., Beck-Sickinger A.G., Wiedemann P., Reichenbach A., Bringmann A. Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J. Neurosci. Res. 2006, 83:538-550.
137. Verstappen A., Van Reeth O., Vaudry H., Pelletier G., Vanderhaeghen J.J. Demonstration of a neuropeptide Y (NPY)-like immunoreactivity in the pigeon retina. Neurosci. Lett. 1986, 70:193-197.
138. Wetzel R.K., Eldred W.D. Specialized neuropeptide Y- and glucagon-like immunoreactive amacrine cells in the peripheral retina of the turtle. Vis. Neurosci. 1997, 14:867-877.
139. Xapelli S., Agasse F., Ferreira R., Silva A.P., Malva J.O. Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Pat. CNS Drug Discov. 2006, 1:315-324.
140. Xapelli S., Bernardino L., Ferreira R., Grade S., Silva A.P., Salgado J.R., Cavadas C., Grouzmann E., Poulsen F.R., Jakobsen B., Oliveira C.R., Zimmer J., Malva J.O. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia. Eur. J. Neurosci. 2008, 27:2089-2102.
141. Xapelli S., Silva A.P., Ferreira R., Malva J.O. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides 2007, 28:288-294.
142. + channels in vascular smooth muscle cells by neuropeptide Y. Pflugers Arch. 1995, 431:110-116.
143. Xu H., Sta Iglesia D.D., Kielczewski J.L., Valenta D.F., Pease M.E., Zack D.J., Quigley H.A. Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes. Invest. Ophthalmol. Vis. Sci. 2007, 48:1674-1682.
144. Yamada T., Brecha N., Rosenquist G., Basinger S. Cholecystokinin-like immunoreactivity in frog retina: localization, characterization, and biosynthesis. Peptides 1981, 2(Suppl. 2):93-97.
145. Yang X.L. Characterization of receptors for glutamate and GABA in retinal neurons. Prog. Neurobiol. 2004, 73:127-150.
146. Yoon H.Z., Yan Y., Geng Y., Higgins R.D. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy. Clin. Exp. Ophthalmol. 2002, 30:424-429.
147. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
148. Zhu B.S., Gibbins I. Synaptic circuitry of neuropeptide-containing amacrine cells in the retina of the cane toad, Bufo marinus. Vis. Neurosci. 1995, 12:919-927.
149. Zhu B.S., Gibbins I. Muller cells in the retina of the cane toad, Bufo marinus, express neuropeptide Y-like immunoreactivity. Vis. Neurosci. 1996, 13:501-508.